The Pediatric and Adolescent Dermatology Office is currently participating in a new study to compare the effectiveness of 5 doses of a study medication in infants requiring treatment for facial hemangioma.

Infants should:

• Be 1 month through 4 months of age (up to 150 days of age)
• Be otherwise healthy
• Have an untreated facial hemangioma

If enrolled, families will receive visits with the Dermatology staff, payment for participation, and study medication at no cost. For more information please call the Pediatric and Adolescent Dermatology Research Office at 858-576-1700 ext 4295.

CSSD Division of Dermatology